CTRI/2012/03/002524招募中2 期
Clinical Evaluation of Punarnavadi Mandura and Dadimadi Ghrita in the Management of Iron Deficiency Anaemia - IMCRP â?? IDA â?? 2010 - 2011
Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Patients of either sex aged between 15 to 60 years.
- •2) Patients with iron deficiency anaemia (Hb 8gm-10gm.%),
- •3) Patients with peripheral blood smear suggestive of Iron deficiency Anaemia
- •4) Willing and able to participate for 14 weeks.
排除标准
- •1. Patients suffering from Thalassemia major / Aplastic anaemia / Sickle cell anaemia.
- •2. Patients with evidence of malignancy.
- •3. Patients suffering from major systemic illness necessitating long term drug treatment
- •(Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, Bleeding disorders, etc.)
- •4. Patients who have a past history of Atrial Fibrillation, Coronary Artery Disease (CAD), Acute
- •Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •5. Symptomatic patient with clinical evidence of Heart failure.
- •6. Patients with poorly controlled Hypertension ( > 160 / 100 mm Hg)
- •7. Patients suffering from Diabetes Mellitus {B.S. (F) > 250 mg/dl.
- •8. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants,
- •anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
- •9. Patients with concurrent serious hepatic disorder (defined as Aspartate Amino
- •Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline
- •Phosphatase (ALP) > 2 times upper normal limit), or Renal Disorders (defined as S. Creatinine
- •>1.2mg/dL), Total Serum Cholesterol & / or Serum Triglycerides > 250 mg/dl, Severe Pulmonary
- •Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease
- •10. Alcoholics and/or drug abusers.
- •11. Pregnant / lactating woman
- •12 H/o hypersensitivity to the trial drug or any of its ingredients.
- •13 Patients who have completed participation in any other clinical trial during the past six (06)
- •14 Any other condition which the Investigator thinks may jeopardize the study.
研究者
相似试验
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the treatment of AnaemiaCTRI/2012/01/002335Department of AYUSH Ministry of Health Family Welfare Government of India150
尚未招募
2 期
Efficacy and Safety of Punarnavadi mandura and Dadimadi Ghrita in Anemia of AdolescentsCTRI/2023/05/052496Central Council for Research in Ayurvedic Sciences,
招募中
2 期
Clinical Study on mandurathi kudineer chooranam for the treatment of anaemiaCTRI/2019/05/019467Ayothidoss Pandithar Hospital
已完成
2 期
Clinical evaluation of Perumbadu Nivarani for vaadha perumbadu(DUB)CTRI/2017/07/008966self10
尚未招募
1 期
Yakritapleeha Vikar (Hepatomegaly & Splenomegaly) me Manadya Gutika aur Shobhanjanadi Kwath ka Chikitsatmak AdhyayaCTRI/2021/11/038245Department of Kayachikitsa Govt Ayurved College Raipur CG